Success Stories: From Discovery to Impact: NIW Approval for Scientist Tackling Neurodegenerative Disorders

Posted by wegreened on January 30, 2026 in Biomedical Sciences, NIW

Client’s Testimonial:

“Thank you so much for sharing the exciting news! Please pass my thanks to Robert and everyone who helped with my case!”

On January 22^nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the field of Biomedical Sciences (Approval Notice).

General Field: Biomedical Sciences

Position at the Time of Case Filing: Postdoctoral Scholar

Country of Origin: China

State of Residence at the Time of Filing: Illinois

Approval Notice Date: January 22^nd, 2025

Processing Time: 2 months, 2 days (Premium Processing Requested)

Case Summary:

Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are among the most devastating illnesses faced by American families. They affect millions of people, carry no cure, and impose an enormous burden on the U.S. healthcare system. Our client, a dedicated biomedical researcher, has committed her career to tackling these challenges by uncovering the genetic and molecular mechanisms that drive such disorders.

Breakthroughs in Molecular Research
Her work has already yielded advances that are reshaping the field. She has refined genetic tools for more precise gene editing, discovered key regulatory pathways of protein quality control, and revealed how protein mislocalization contributes to disease progression. These insights provide crucial building blocks for the development of therapies that can slow, stop, or even reverse the progression of neurodegenerative conditions.

Independent researchers worldwide have adopted her findings to fuel further innovation, applying her discoveries to new approaches in cancer research and advanced gene-editing systems. This broad uptake underscores the influence of her contributions well beyond her own laboratory.

Recognition and Influence
Her scholarship is reflected in a growing body of publications, 4 peer-reviewed articles (2 first-authored, 1 co-first-authored), 1 abstract, and nearly 90 citations. Several of her papers rank among the top 20% most cited in Molecular Biology & Genetics, a clear indication of their value to the global scientific community.

Peers have not only cited her work but have also emphasized its national relevance. One expert wrote:

“By improving the specificity of this method, [Client] is facilitating efforts to study and treat a wide range of hard-to-treat neurodegenerative diseases, such as Parkinson’s and Alzheimer’s disease. As such, her work is nationally significant for healthcare in the United States.”

Approval and the Road Ahead
Recognizing both the substantial merit of her research and her proven ability to continue driving innovation, USCIS approved her NIW petition. With the dedicated guidance of North America Immigration Law Group (NAILG), she is now positioned to continue her work in the United States, where her discoveries will help shape the future of healthcare and bring hope to patients and families impacted by neurodegenerative disease.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%